Margin re‐excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model

Abstract

The strategy of re-excising close margins resulted in a predicted cost of $18.8 million per year. This does not include hospital costs, the cost of surgical complications after re-excision, and underestimates the potential savings by using Medicare reimbursement rates.